Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Desai
    Member
    • Dec 2013
    • 18

    #1

    Ngs

    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.
  • lethalfang
    Member
    • Aug 2011
    • 95

    #2
    Originally posted by Desai View Post
    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.
    1) Direct comparison of Illumina and 454: http://www.plosone.org/article/info%...l.pone.0030087

    2) I think it means paired end (2 x 150) vs. single read (1 x 150).

    Comment

    • AllSeq
      Registered Vendor
      • Oct 2013
      • 138

      #3
      Originally posted by Desai View Post
      Dear Friends,

      I am newbie in sequencing field. I have some questions in my mind.
      (1) Why we prefer illumina more than 454 sequencing, when 454 gives
      400bp reads length compare to ilumina which gives only 150 reads length?
      (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
      stand for. Is is for single and pair?
      Thank you in advance for answer or just view.
      454 actually does a bit better than 400b reads - some users are able to produce close to 1000b reads. Even though Illumina has shorter reads (up to 2X300 on the MiSeq), it beat out 454 for one simple reason - price. Illumina's platforms generate data at a cost of about 1/100th what it would cost to generate on the 454. Roche simply didn't improve their system as fast as the other platforms (Illumina, Ion Torrent and even PacBio). As such, they've made the decision to shut down the platform in 2016.

      You can learn more about the performance specs and costs of the various platforms on our NGS Knowledge Bank.
      AllSeq - The Sequencing Marketplace
      [email protected]
      www.AllSeq.com

      Comment

      • Desai
        Member
        • Dec 2013
        • 18

        #4
        I got your point. I thought it related to quality means illumina gave better quality than Roche 454.

        Comment

        • AllSeq
          Registered Vendor
          • Oct 2013
          • 138

          #5
          Originally posted by Desai View Post
          I got your point. I thought it related to quality means illumina gave better quality than Roche 454.
          454 has decent quality, but it definitely has a homopolymer issue - strings of the same base are challenging for the detection system to get right, leading to indel errors. Ion Torrent suffers from the same issue (due to similar chemistries), but they've done more to correct it.
          AllSeq - The Sequencing Marketplace
          [email protected]
          www.AllSeq.com

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...